DK0810856T3 - Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse - Google Patents

Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse

Info

Publication number
DK0810856T3
DK0810856T3 DK96907041T DK96907041T DK0810856T3 DK 0810856 T3 DK0810856 T3 DK 0810856T3 DK 96907041 T DK96907041 T DK 96907041T DK 96907041 T DK96907041 T DK 96907041T DK 0810856 T3 DK0810856 T3 DK 0810856T3
Authority
DK
Denmark
Prior art keywords
dosage form
banded
release dosage
prolonged release
active agent
Prior art date
Application number
DK96907041T
Other languages
Danish (da)
English (en)
Inventor
Patrick S-L Wong
David Edmil Edgren
Liang C Dong
Vincent J Ferrari
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0810856T3 publication Critical patent/DK0810856T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96907041T 1995-02-24 1996-02-09 Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse DK0810856T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/394,074 US5534263A (en) 1995-02-24 1995-02-24 Active agent dosage form comprising a matrix and at least two insoluble bands
PCT/US1996/001848 WO1996025922A2 (en) 1995-02-24 1996-02-09 Banded prolonged release active agent dosage form

Publications (1)

Publication Number Publication Date
DK0810856T3 true DK0810856T3 (da) 2001-05-07

Family

ID=23557446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907041T DK0810856T3 (da) 1995-02-24 1996-02-09 Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse

Country Status (17)

Country Link
US (4) US5534263A (fi)
EP (1) EP0810856B1 (fi)
JP (1) JP3955320B2 (fi)
KR (1) KR100465268B1 (fi)
CN (1) CN1142771C (fi)
AT (1) ATE200421T1 (fi)
AU (1) AU703681B2 (fi)
DE (1) DE69612481T2 (fi)
DK (1) DK0810856T3 (fi)
ES (1) ES2155931T3 (fi)
FI (1) FI973452A0 (fi)
GR (1) GR3035743T3 (fi)
HK (1) HK1005794A1 (fi)
NO (1) NO319216B1 (fi)
NZ (1) NZ303809A (fi)
PT (1) PT810856E (fi)
WO (1) WO1996025922A2 (fi)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
SE9603667D0 (sv) * 1996-10-08 1996-10-08 Astra Ab Pharmaceutical compositions
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
PL337813A1 (en) * 1997-06-11 2000-09-11 Procter & Gamble Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
ATE285226T1 (de) * 1997-08-11 2005-01-15 Alza Corp Gastrische zurückhalteform zur verlängerten freisetzung eines wirkstoffs
IN186245B (fi) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
PT1021171E (pt) * 1997-10-09 2003-10-31 Dexcel Pharma Technologies Ltd Sistema de administracao de farmacos no tracto gastrointestinal de libertacao total prolongada
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1413296A1 (en) * 1998-05-07 2004-04-28 ALZA Corporation Method of fabricating a banded prolonged release active agent dosage form
US6365183B1 (en) * 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
KR20070051953A (ko) 1998-11-02 2007-05-18 엘란 코포레이션, 피엘씨 다입자 변형 방출 조성물
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
WO2000038650A1 (en) * 1998-12-23 2000-07-06 Alza Corporation Gastric retention dosage form having multiple layers
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
HU230828B1 (en) 1999-10-29 2018-08-28 Euro Celtique Sa Controlled release hydrocodone formulations
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
US7056531B1 (en) 2000-05-04 2006-06-06 Nature's Way Products, Inc. Sustained release compositions for orally administered substances and methods
CN101317825A (zh) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
ITMI20012481A1 (it) 2001-11-23 2003-05-23 Univ Parma Sistemi modulari per il rilascio controllato di sostanza a controllo spaziale e temporale
US20040052848A1 (en) * 2002-05-23 2004-03-18 Xiu-Xiu Cheng Biguanide formulations
WO2004004635A2 (en) * 2002-07-02 2004-01-15 Board Of Regents, The University Of Texas System Radiolabeled compounds and liposomes and their methods of making and using the same
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
JP3811127B2 (ja) * 2003-01-30 2006-08-16 株式会社東芝 情報記録装置及び情報記録方法
AR046410A1 (es) * 2003-09-18 2005-12-07 Cephalon Inc Composiciones farmaceuticas para la liberacion modificada de modafinilo
CN102697704A (zh) * 2003-09-26 2012-10-03 阿尔扎公司 阿片类与非阿片类镇痛药的控释制剂
WO2005072079A2 (en) * 2003-09-26 2005-08-11 Alza Coporation Drug coating providing high drug loading and methods for providing the same
EP1663145B1 (en) * 2003-09-26 2011-04-06 ALZA Corporation Oros-push-stick for controlled delivery of active agents
AU2004275835B2 (en) * 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
JP2007506753A (ja) * 2003-09-26 2007-03-22 アルザ・コーポレーシヨン 帯締めされたエンジンを包含する改良された制御放出投薬形態物
AU2004285531A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of metformin
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US20110140217A1 (en) * 2004-02-26 2011-06-16 Grandis, Inc. Spin transfer magnetic element with free layers having high perpendicular anisotropy and in-plane equilibrium magnetization
US6992359B2 (en) * 2004-02-26 2006-01-31 Grandis, Inc. Spin transfer magnetic element with free layers having high perpendicular anisotropy and in-plane equilibrium magnetization
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006063078A2 (en) * 2004-12-08 2006-06-15 Elan Corporation, Plc Topiramate pharmaceuticals composition
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
WO2006113568A2 (en) * 2005-04-19 2006-10-26 Alza Corporation Controlled delivery dosage form of tramadol and gabapentin
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
EP1901720A2 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Improved dosage forms for movement disorder treatment
WO2007011972A2 (en) * 2005-07-19 2007-01-25 Inverseon, Inc. Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
US20070077309A1 (en) * 2005-09-30 2007-04-05 Wong Patrick S Banded controlled release nanoparticle active agent formulation dosage forms and methods
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US9011930B2 (en) * 2006-05-01 2015-04-21 Zycal Bioceuticals Healthcare Company, Inc. Nutritional supplement and use thereof
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
CA2662123C (en) * 2006-08-30 2015-12-01 Jagotec Ag Controlled release oral dosage formulations comprising a core and one or more barrier layers
WO2008079404A2 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
US10446209B2 (en) 2009-08-10 2019-10-15 Samsung Semiconductor Inc. Method and system for providing magnetic tunneling junction elements having improved performance through capping layer induced perpendicular anisotropy and memories using such magnetic elements
US8913350B2 (en) * 2009-08-10 2014-12-16 Grandis, Inc. Method and system for providing magnetic tunneling junction elements having improved performance through capping layer induced perpendicular anisotropy and memories using such magnetic elements
US20110031569A1 (en) * 2009-08-10 2011-02-10 Grandis, Inc. Method and system for providing magnetic tunneling junction elements having improved performance through capping layer induced perpendicular anisotropy and memories using such magnetic elements
US9130151B2 (en) 2010-01-11 2015-09-08 Samsung Electronics Co., Ltd. Method and system for providing magnetic tunneling junctions usable in spin transfer torque magnetic memories
US8254162B2 (en) 2010-01-11 2012-08-28 Grandis, Inc. Method and system for providing magnetic tunneling junctions usable in spin transfer torque magnetic memories
US8546896B2 (en) 2010-07-16 2013-10-01 Grandis, Inc. Magnetic tunneling junction elements having magnetic substructures(s) with a perpendicular anisotropy and memories using such magnetic elements
EP2605760B1 (en) * 2010-08-18 2017-01-11 Johnson & Johnson Consumer Inc. Tablet sleeve for improved performance
AU2011342893A1 (en) 2010-12-13 2013-05-02 Purdue Pharma L.P. Controlled release dosage forms
US8766383B2 (en) 2011-07-07 2014-07-01 Samsung Electronics Co., Ltd. Method and system for providing a magnetic junction using half metallic ferromagnets
US9580896B2 (en) 2014-07-05 2017-02-28 John David Hopkins Apparatus and method for prolonged active agent in aqueous systems
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
WO2018017553A2 (en) 2016-07-19 2018-01-25 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4290426A (en) * 1978-05-04 1981-09-22 Alza Corporation Dispenser for dispensing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5266332A (en) * 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
US5629008A (en) 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
PT1021171E (pt) * 1997-10-09 2003-10-31 Dexcel Pharma Technologies Ltd Sistema de administracao de farmacos no tracto gastrointestinal de libertacao total prolongada
US6337091B1 (en) * 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents

Also Published As

Publication number Publication date
US5534263A (en) 1996-07-09
MX9706484A (es) 1997-11-29
JP3955320B2 (ja) 2007-08-08
NZ303809A (en) 1999-04-29
EP0810856A2 (en) 1997-12-10
KR19980702469A (ko) 1998-07-15
FI973452A (fi) 1997-08-22
AU703681B2 (en) 1999-04-01
EP0810856B1 (en) 2001-04-11
JPH11500728A (ja) 1999-01-19
DE69612481T2 (de) 2001-07-26
KR100465268B1 (ko) 2005-04-06
ATE200421T1 (de) 2001-04-15
AU5022696A (en) 1996-09-11
CN1142771C (zh) 2004-03-24
US6316028B1 (en) 2001-11-13
NO319216B1 (no) 2005-07-04
DE69612481D1 (de) 2001-05-17
WO1996025922A2 (en) 1996-08-29
WO1996025922A3 (en) 1996-10-03
FI973452A0 (fi) 1997-08-22
HK1005794A1 (en) 1999-01-29
ES2155931T3 (es) 2001-06-01
GR3035743T3 (en) 2001-07-31
NO973840L (no) 1997-10-22
PT810856E (pt) 2001-09-28
CN1175901A (zh) 1998-03-11
US5667804A (en) 1997-09-16
NO973840D0 (no) 1997-08-21
US6020000A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
DK0810856T3 (da) Med bånd forsynet doseringsform af aktivt middel med forlænget frigivelse
NO2017011I1 (no) Buprenorfin
ATE220896T1 (de) Hydrogelformulierung mit gesteuerter freisetzung
ID27504A (id) Formulasi oral baru
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
ATE258044T1 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
ES2183841T3 (es) Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
DE60019334D1 (de) Antivirale arznei
DK1112060T3 (da) Doseringsform anvendende flydende formulering
MX9705806A (es) Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion.
AR006565A1 (es) Suspensiones acuosas de beta-ciflutrina
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
ES2170377T3 (es) Composicion que contiene quitosana.
CA2207098A1 (en) Banded prolonged release active agent dosage form
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
MX9706412A (es) Uso de aerogeles inorganicos en la industria farmaceutica.